
Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5DQVlKYjBhS3d4cDZTb0VZemF4aERBOWJMUWx3d1g4VlJiQnBXWDFyb3B1OHdrMjEtdVdkMTNWOGE4SzVtYXJnQlVFeVh3b2lOX2k5dGtMQWJnRjMtMmM0?oc=5" target="_blank">Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">RSNA Journals</font>
